Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000363797 | SCV000399295 | likely benign | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697667 | SCV000524269 | benign | not provided | 2018-06-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001697667 | SCV002463135 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000363797 | SCV002514260 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278441 | SCV002565305 | likely benign | Ehlers-Danlos syndrome | 2018-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002450878 | SCV002735866 | likely benign | Cardiovascular phenotype | 2019-03-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |